Publication output of RANZCR radiation oncologists in 2022-23.

IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Journal of Medical Imaging and Radiation Oncology Pub Date : 2024-11-11 DOI:10.1111/1754-9485.13807
Daniel Roos, Lisa Milner, Therese Kang, Emma Quinn, Wee Loon Ong
{"title":"Publication output of RANZCR radiation oncologists in 2022-23.","authors":"Daniel Roos, Lisa Milner, Therese Kang, Emma Quinn, Wee Loon Ong","doi":"10.1111/1754-9485.13807","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this work was to determine the current publication output of Royal Australian and New Zealand College of Radiologists radiation oncologists (ROs) to serve as a baseline contributing to future assessment of the effectiveness of the College's Research Action Plan 2024-26.</p><p><strong>Methods: </strong>An online survey was sent to all ROs in the College's member database in March-April 2024 requesting a list of publications between 2022 and 2023. A PubMed search was performed to cross-check the self-reported publications. Given the low response rate (8%), an additional PubMed search was performed for the non-responders. The primary outcomes were publication proportions and rates, and the secondary outcomes were demographic correlates (gender, country, seniority).</p><p><strong>Results: </strong>There were 536 eligible ROs (56% males; 80% practicing in Australia; median 12.4 years post-Fellowship) with 1,012 unique publications identified. The proportions of ROs with at least one publication in any-, first- and last-author positions averaged 45%, 15% and 17% per year, respectively. On multivariable analysis, there were statistically significant differences in publications by seniority (higher proportions of last-authorships but lower proportions of first-authorships, for those ≥5 years post-Fellowship) and by country (lower any-, and last-authorships for New Zealand [NZ] than Australia or Singapore). The mean numbers of any-, first- and last-authorships were 1.6, 0.18 and 0.29 per RO per year, respectively. On multivariable analysis, there were statistically significant differences by gender (males had more any-, and first-authorships), seniority (senior ROs had more last-authorships but less first-authorships) and country (lower numbers of any-, and last-authorships for New Zealand).</p><p><strong>Conclusion: </strong>This organization-wide study provides comprehensive baseline RO publication data and identifies opportunities for the College to further address correlated disparities.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Imaging and Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1754-9485.13807","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The purpose of this work was to determine the current publication output of Royal Australian and New Zealand College of Radiologists radiation oncologists (ROs) to serve as a baseline contributing to future assessment of the effectiveness of the College's Research Action Plan 2024-26.

Methods: An online survey was sent to all ROs in the College's member database in March-April 2024 requesting a list of publications between 2022 and 2023. A PubMed search was performed to cross-check the self-reported publications. Given the low response rate (8%), an additional PubMed search was performed for the non-responders. The primary outcomes were publication proportions and rates, and the secondary outcomes were demographic correlates (gender, country, seniority).

Results: There were 536 eligible ROs (56% males; 80% practicing in Australia; median 12.4 years post-Fellowship) with 1,012 unique publications identified. The proportions of ROs with at least one publication in any-, first- and last-author positions averaged 45%, 15% and 17% per year, respectively. On multivariable analysis, there were statistically significant differences in publications by seniority (higher proportions of last-authorships but lower proportions of first-authorships, for those ≥5 years post-Fellowship) and by country (lower any-, and last-authorships for New Zealand [NZ] than Australia or Singapore). The mean numbers of any-, first- and last-authorships were 1.6, 0.18 and 0.29 per RO per year, respectively. On multivariable analysis, there were statistically significant differences by gender (males had more any-, and first-authorships), seniority (senior ROs had more last-authorships but less first-authorships) and country (lower numbers of any-, and last-authorships for New Zealand).

Conclusion: This organization-wide study provides comprehensive baseline RO publication data and identifies opportunities for the College to further address correlated disparities.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2022-23 年 RANZCR 放射肿瘤学家的出版成果。
导言:这项工作的目的是确定澳大利亚和新西兰皇家放射肿瘤学院放射肿瘤学家(ROs)目前的出版物产出,作为未来评估学院《2024-26 年研究行动计划》有效性的基线:2024 年 3 月至 4 月,向学院会员数据库中的所有放射科医师发送了一份在线调查,要求他们提供 2022 年至 2023 年期间发表的论文清单。为核对自报的出版物,还进行了 PubMed 搜索。鉴于回复率较低(8%),我们对未回复者进行了额外的 PubMed 搜索。主要结果是发表论文的比例和比率,次要结果是人口统计学相关因素(性别、国家、资历):共有 536 名符合条件的研究员(56% 为男性;80% 在澳大利亚执业;获得研究员资格后的时间中位数为 12.4 年)发表了 1,012 篇独特的论文。在任何作者、第一作者和最后作者位置上至少发表过一篇论文的研究员比例每年平均分别为45%、15%和17%。在多变量分析中,不同资历(获得研究员资格后≥5 年的人员中,最后作者的比例较高,但第一作者的比例较低)和不同国家(新西兰的任何作者和最后作者的比例低于澳大利亚或新加坡)的人员发表的论文在统计上存在显著差异。每名研究员每年获得的任意、第一和最后署名的平均数量分别为 1.6、0.18 和 0.29。在多变量分析中,性别(男性拥有更多的任意和第一作者)、资历(资深研究员拥有更多的最后作者,但第一作者较少)和国家(新西兰的任意和最后作者数量较少)之间的差异具有统计学意义:这项全组织范围的研究提供了全面的研究干事发表论文的基准数据,并为学院进一步解决相关差异问题提供了机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.30
自引率
6.20%
发文量
133
审稿时长
6-12 weeks
期刊介绍: Journal of Medical Imaging and Radiation Oncology (formerly Australasian Radiology) is the official journal of The Royal Australian and New Zealand College of Radiologists, publishing articles of scientific excellence in radiology and radiation oncology. Manuscripts are judged on the basis of their contribution of original data and ideas or interpretation. All articles are peer reviewed.
期刊最新文献
Paraganglioma and phaeochromocytoma in adult Fontan patients. Radiotherapy for node-positive prostate cancer in the PSMA-PET era: The need for prospective clinical trials. Comparing DCE-MRI and DSA: Understanding the embolization of hypervascular spinal metastases. Publication output of RANZCR radiation oncologists in 2022-23.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1